Loading...
NYSE: MS
Morgan Stanley
Financial Services · Financial - Capital Markets
●S&P 500 since 1993
Market Cap
$256.38B
52w High
$192.68
52w Low
$94.33
P/E
15.04
Volume
9.70M
Outstanding Shares
1.59B
Price vs Fundamentals
Why The Stock Is Moving
Optimism is getting priced inModerate confidence
1Y Price: 34.03%Revenue (TTM): 11.48%FCF (TTM): -751.86%P/E: 83rd pct
What changed
The stock rose 34.03% over the last year. Revenue grew 11.48% over the trailing twelve months. Operating margin moved from 17.06% to 19.09%. Free cash flow declined 751.86% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/E range (83rd percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 19.09% — continued expansion would be needed to justify the premium. Revenue growth of 11.48% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia.
CEOEdward N. Pick
SectorFinancial Services
IndustryFinancial - Capital Markets
Employees81,000
IPO dateFeb 23, 1993
Valuation
Forward P/E—
EV/EBITDA24.15
Enterprise value$642.76B
Price / Book2.30
Stock splits
Jan 27, 20002:1
Jan 15, 19972:1
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth11.08%
Gross margin57.07%▲2.62%vs FY2024
Operating margin19.09%▲11.92%vs FY2024
ROE15.1%▲17.89%vs FY2024
Analyst consensus
RatingBuy
Target price$196.00▲21.39%
27
Buy
23
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 15, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
$2.13
$1.98
Q4FY25
ActualEst.
$2.80
$2.10
Q1FY26
ActualEst.
$2.68
$2.43
Q2FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$15.6B
$16.07B
Q4FY25
ActualEst.
$17.08B
$16.69B
Q1FY26
ActualEst.
$16.76B
$17.74B
Q2FY26
Next Est.
—